C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
GTBIF US MSO

Green Thumb Industries

OTCMKTS · GTBIF

Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.

$6.36
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
56/100 composite
Fundamentals77
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

CIN rates Green Thumb Industries Neutral with a 56 composite score and low conviction at 2/5. Fundamentals provide the principal support at 77, driven by strong operating-margin, gross-margin, market-capitalization and cash-runway subscores. The regulatory pillar contributes a middling 58: a favorable jurisdiction posture and no enforcement hits are offset by weak filing cadence. Market support remains limited at 40 because no quote was available through institutional pricing feeds. Editorial contribution is lowest at 30, reflecting no newsroom or brief activity in CIN newsroom coverage. The resulting profile supports neither an Overweight stance nor an Underweight call, leaving valuation confirmation and improved information flow as prerequisites for a more directional rating.

Licensed fundamentals data show year-over-year revenue growth of 7.4%, a solid but less powerful component than profitability. Gross margin stands at approximately 48.1%, while operating margin reaches about 13.6%; corresponding subscores of 80.2 and 87.4 anchor the fundamentals assessment. EBITDA of roughly $284.4 million and net income near $121.3 million reinforce the stable financial condition, while the positive-EBITDA cash-runway classification earns the pillar’s highest subscore at 90. Market capitalization of approximately $1.56 billion also supports the 87.7 size-tier subscore. Primary regulatory filings show the latest filing dated June 18, 2026, with four events during the prior 180 days but none during the latest 90 days. That lapse explains the 25 cadence subscore despite stronger jurisdiction and enforcement readings of 80 each.

The clearest forward catalyst is confirmation that the fundamentals pillar can retain its margin strength while improving the pace of growth. Another primary regulatory filing that preserves the current gross and operating margin profile, alongside revenue expansion above the present 7.4% rate, would reinforce earnings quality and create scope for the composite to move beyond Neutral. Better filing cadence would also improve visibility, but the rating remains anchored most directly to operating performance because fundamentals exceed every other pillar by at least 19 points. The single most important signal to watch is whether the next reported period delivers faster year-over-year revenue growth without sacrificing the 13.6% operating margin.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
325 WEST HURON STREET, SUITE 700, CHICAGO, IL, 60654
Phone
312-471-6720
Auditor
as stated in their attestation report
SEC CIK
1795139
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$1.56B
Enterprise value
$1.77B
P/E ratio
13.9
PEG ratio
1.79
Price to book
0.82
Price to sales
1.30
EV / EBITDA
3.48
Revenue (TTM)
$1.20B
Gross profit (TTM)
$575.3M
EBITDA
$284.4M
Operating margin
13.6%
Profit margin
10.1%
Rev growth YoY
7.4%
Return on equity
6.6%
Return on assets
3.1%
EPS (TTM)
$0.51
EPS est. current year
$0.12
Wall St. target price
$15.67
Shares outstanding
195.1M
Insider ownership
1.9%
Institutional ownership
8.2%
Beta
0.93
Full-time employees
4,900
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Green Thumb Industries (GTBIF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Green Thumb Industries (GTBIF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $21.38.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, insider selling. (2 bullish signals, 3 bearish signals.)

Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for GTBIF are maintained by Cannabis Investor News and refreshed throughout the trading day.